Top 50 Life Science Startup Investors in Middle East (October 2023)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
TRANGELS
VC Fund
|
4 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Biotechnology, Energy, Manufacturing | $29k–$1.4M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Egypt Ventures
VC Fund
|
4 | Egypt, United States, The Netherlands | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $28k–$3M |
|
Sapir Venture Partners
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$5M |
|
Pitango VC
VC Fund
|
3 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $2M–$42M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $10M–$120M |
|
Israel Innovation Authority
VC Fund
|
3 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Medical Device, Software | $91k–$4M |
|
Neo Ventures
VC Fund
|
3 | Israel, United Kingdom, Estonia | Seed, Series A | Software, Artificial Intelligence, Aerospace | $1.1M–$1.6M |
|
FutuRx
VC Fund
|
2 | Israel | Health Care, Biotechnology, Pharmaceutical | ||
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Pre-Seed, Seed, Series A | Health Care, FinTech, E-Learning | $300k–$8M |
|
Cairo Angels
VC Fund
|
2 | Egypt, United States, Lebanon | Seed, Angel, Pre-Seed | E-Commerce, Mobile, Marketplace | $50k–$3M |
|
LoftyInc Capital Management
VC Fund
|
2 | United States, Nigeria, Egypt | Seed, Pre-Seed, Series A | FinTech, Financial Services, Software | $100k–$15M |
|
Pontifax
VC Fund
|
2 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.8M–$100M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$80M |
|
Takeda Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $8M–$100M |
|
Averroes Ventures
VC Fund
|
2 | Egypt, United Arab Emirates | Seed, Convertible Note | Transportation, Logistics, Delivery | $500k–$1.4M |
|
Genesis Park
VC Fund
|
2 | United States, Israel | Private Equity, Debt Financing | Manufacturing, Health Care, Natural Resources | $2.5M–$200M |
|
Cancer Focus Fund
VC Fund
|
2 | Israel | Series A | Biotechnology, Medical, Life Science | |
|
Ahmed Abdelhamid
Angel
|
2 | Egypt, United States | Seed, Convertible Note | Aerospace, Biopharma, Life Science | |
|
Endure Capital
VC Fund
|
2 | Egypt, United States, United Kingdom | Seed, Series A, Series B | Health Care, Software, E-Commerce | $225k–$34M |
|
aMoon Fund
VC Fund
|
1 | United States, Israel, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | $6M–$63M |
|
Trendlines Group
VC Fund
|
1 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $500k–$7.5M |
|
Trust Ventures
VC Fund
|
1 | United States, Israel | Seed, Series A, Series B | Health Care, Information Technology, Insurance | $3M–$6M |
|
Milk and Honey Investments
VC Fund
|
1 | Israel | Series A | Life Science, Organic Food, Biotechnology | |
|
Alex Angels
VC Fund
|
1 | Egypt | Seed, Pre-Seed, Convertible Note | E-Commerce, Marketplace, Mobile Apps | $28k–$1.2M |
|
Aries Holding BV
VC Fund
|
1 | The Netherlands, Israel | Seed, Pre-Seed | FinTech, Finance, Payments | |
|
Hult Alumni Angels
VC Fund
|
1 | Egypt | Seed | Biopharma, Life Science, Biotechnology | |
|
RMGP Biopharma Investment Fund
VC Fund
|
1 | Israel | Series B | Biotechnology, Health Care, Pharmaceutical | |
|
Sectoral Asset Management
VC Fund
|
1 | United States, United Kingdom, France | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Medical | $20M–$230M |
|
Arba Finance Ltd.
VC Fund
|
1 | Israel | Series A | AgTech, Medical, Cannabis | |
|
Essam Abdelhadi
Angel
|
1 | Egypt | Seed | Biopharma, Life Science, Biotechnology | |
|
Clal Biotechnology Industries
VC Fund
|
1 | Israel, United States | Series A, Series B | Biotechnology, Health Care, Medical | $4M–$55M |
|
Arkin Holdings
VC Fund
|
1 | Israel, United States, Switzerland | Series A, Seed | Biotechnology, Health Care, Medical Device | $5.5M–$20M |
|
Arc Impact
VC Fund
|
1 | Israel, United States, United Kingdom | Seed, Pre-Seed | Health Care, AgTech, EdTech | $2.5M–$6M |
|
Angel
VC Fund
|
1 | United States, United Kingdom, Singapore | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | |
|
Stony Hill Corp
VC Fund
|
1 | Israel | Series A | AgTech, Medical, Cannabis | |
|
Almoayed Ventures
VC Fund
|
1 | United States, India, United Arab Emirates | Seed, Series A, Pre-Seed | Health Care, Information Technology, Financial Services | $1.2M–$13M |
|
Bio Capital Impact Fund
VC Fund
|
1 | Israel | Medical, Health Care, Life Science | ||
|
Emirates Angels
VC Fund
|
1 | United Arab Emirates | Pre-Seed | Health Care, Life Science | |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$115M |
|
Life Science Angels
VC Fund
|
1 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical | $605k–$20M |
|
M Ventures
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.1M–$67M |
|
HBL Hadasit Bio Holdings
VC Fund
|
1 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Office of the Chief Scientist
VC Fund
|
1 | Israel | Seed | Health Care, Biotechnology, Hardware | $1M–$1M |
|
OTV
VC Fund
|
1 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | $5M–$50M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Belgium | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
Talisman Capital Partners
VC Fund
|
1 | United States, Israel, Hong Kong | Series A, Seed, Series B | Information Services, Pet, News | $15M–$17M |
|
TPY Capital
VC Fund
|
1 | Israel, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Big Data | $3M–$21M |
|
Ibtikar Fund
VC Fund
|
1 | Palestinian Territory, United States, Jordan | Seed, Pre-Seed | E-Commerce, Artificial Intelligence, Health Care | $60k–$600k |
|
Grove Ventures
VC Fund
|
1 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Machine Learning, Software | $3.3M–$74M |
| Access all 50 investors in Middle East Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Biotechnology, Energy, Manufacturing
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 31
- Round size: Seed $67k–$1.4M; Angel $29k–$500k; Pre-Seed $35k–$400k
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- & New Me — Andnewme is a health platform that serves with the motto "only aesthetics". You can get information about aesthetic treatments and find the doctor you are looking for!
- Biftek — The future of meat starts here. We produce growth medium to make cultured meat affordable.
- Nanomik Biotechnology — Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Egypt, United States, The Netherlands
Investor stats
- Total investments: 20
- Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- MNT-Halan — MNT-Halan is a microfinance lending and payments company.
- Gahez Market — Gahez Market Online store
- Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $1.3M–$5M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
- Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 243
- Round size: Series A $2M–$25M; Series B $7M–$35M; Series C $7.5M–$42M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
- QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 419
- Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 107
- Round size: Seed $500k–$4M; Grant $91k–$2.5M; Pre-Seed $150k–$1M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- BloomX — Helping nature do its magic with the power of technology
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United Kingdom, Estonia
Investor stats
- Total investments: 13
- Round size: Seed $1.1M–$1.6M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- EnduroSat — EnduroSat designs, builds and operates class-leading NanoSats for a range of commercial, exploration and science missions. We focus on inter-satellite connectivity and space data applications
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, FinTech, E-Learning
- Stage:Pre-Seed, Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 19
- Round size: Seed $1.6M–$8M; Pre-Seed $300k–$760k
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
- Peech — Peech, an automatic video editing tool, analyzes the verbal content of your video, edits it into a short & catchy version and enhances it with suited visual elements that attract your audience.
- Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more...Investment focus
- Industry: E-Commerce, Mobile, Marketplace
- Stage:Seed, Angel, Pre-Seed
- Geography: Egypt, United States, Lebanon
Investor stats
- Total investments: 31
- Round size: Seed $50k–$3M; Angel $200k–$300k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Sprints — home page Description
- The Fashion Kingdom — Fashion, Sneakers for men, women, and kids
LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Nigeria, Egypt
Investor stats
- Total investments: 111
- Round size: Seed $100k–$3.2M; Pre-Seed $100k–$2M; Series A $250k–$15M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Craydel — Get Professional career guidance based on Psychometric Assessments and get scholarships to the best MBA, Engineering, Medical, Education online and on campus courses in Africa and Abroad.
- EMTECH — For Modern Central Banking
- Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 93
- Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 69
- Round size: Series A $5.9M–$65M; Series B $7.5M–$80M; Series C $300k–$70M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
- ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
- Nucleome Therapeutics — Decoding the dark matter of the human genome to deliver first-in-class precision medicinesDiscover More
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 95
- Round size: Series A $8M–$43M; Series B $11M–$100M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.
Show more...Investment focus
- Industry: Transportation, Logistics, Delivery
- Stage:Seed, Convertible Note
- Geography: Egypt, United Arab Emirates
Investor stats
- Total investments: 5
- Round size: Seed $500k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Natural Resources
- Stage:Private Equity, Debt Financing
- Geography: United States, Israel
Investor stats
- Total investments: 16
- Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
- WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
- Le Sueur Incorporated — Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting.
Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Nectin Therapeutics — NectinTX is a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy agents.
Ahmed Abdelhamid is Partner at Endure Capital. He attended Vlerick Business School.
Show more...Investment focus
- Industry: Aerospace, Biopharma, Life Science
- Stage:Seed, Convertible Note
- Geography: Egypt, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Wright Electric, Inc. — Wright Electric, Inc. is building technologies for large commercial airplanes. The company is currently developing their flagship Airplane, the Wright 1, which will be a 186-seat single aisle airliner with an 800 mile range. The company hopes to achieve entry to service for the Wright 1 by 2030 and is working with commercial airlines includingeasyJet and VivaAerobus. In addition to the newly announced U.S. DOE’s ARPA-E funding, the company is funded by Y Combinator, the Clean Energy Trust and venture funds.
Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Egypt, United States, United Kingdom
Investor stats
- Total investments: 59
- Round size: Seed $225k–$6.4M; Series A $1M–$34M; Series B $6M–$14M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
- Pylon — Pylon provides water and electricity distribution companies, in emerging markets, with a platform for managing their customers and infrastructure.
- Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!aMoon is a leading healthtech & life sciences venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 49
- Round size: Series A $6M–$63M; Series B $30M–$35M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $7.3M in 2019
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Eleos Health — Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care.
- Ultima Genomics — Ultima Genomics, Inc is revolutionizing DNA sequencing technology with the UG100 by providing scalability for the $100 genome
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 56
- Round size: Seed $500k–$3M; Series A $2.3M–$7.5M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- PlanetWatchers — Highly accurate crop growth, wind, hail and flood damage assessments at scale. Supporting the crop insurance industry with acreage and claims validation.
Trust Ventures is a venture capital firm that focuses on startups and provides knowledge and expertise in incumbent-heavy industries. The firm was founded in 2018 and is based in Austin, Texas, United States.
Show more...Investment focus
- Industry: Health Care, Information Technology, Insurance
- Stage:Seed, Series A, Series B
- Geography: United States, Israel
Investor stats
- Total investments: 36
- Round size: Seed $3M–$6M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
- Thesis — Thesis offers personalized brain supplements that cater to all types of brains. They create potent nutritional compounds to improve mental function and provide individualized suggestions depending on their customers' goals and brain chemistry.
- StellarFi — We Pay Your Bills, So YouCan Build Credit. With Stellar your bills are paid on time and on your terms.
The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.
Show more...Investment focus
- Industry: Life Science, Organic Food, Biotechnology
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Alex Angels is an investment management company that helps investors to invest in early-stage companies with strong management teams. The company specializes in the fields of financial services, financial exchange, and investments. Alex Angels was founded in 2016 and headquartered in Al Iskandariyah, Egypt.
Show more...Investment focus
- Industry: E-Commerce, Marketplace, Mobile Apps
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Egypt
Investor stats
- Total investments: 22
- Round size: Seed $100k–$1.2M; Pre-Seed $28k–$100k
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- CardoO — Welcome To Our InnovationsExplore
- SIDEUP — SIDEUP provides you with all the necessary tools to grow your business through a hassle-free experience from local and global logistics support, storage services, and innovative and real-time dashboards.
- Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
financial holding company / investments
Show more...Investment focus
- Industry: FinTech, Finance, Payments
- Stage:Seed, Pre-Seed
- Geography: The Netherlands, Israel
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
- Diptera — Developing technology to fight mosquitoes with mosquitoes.
- Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.
Hult Alumni Angels
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: Egypt
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 46
- Round size: Series B $20M–$70M; Series C $40M–$80M; Post-IPO Equity $23M–$230M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
- Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
- Garuda Therapeutics — Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
Investment banking boutique based in Tel Aviv since 1978.
Show more...Investment focus
- Industry: AgTech, Medical, Cannabis
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Essam Abdelhadi
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Seed
- Geography: Egypt
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 21
- Round size: Seed $5.5M–$6M; Series A $18M–$20M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Arc Impact is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, AgTech, EdTech
- Stage:Seed, Pre-Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 7
- Round size: Seed $2.5M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Virtual Internships — The only platform that provides guaranteed remote internships in your chosen industry and region to gain the skills employers seek.
Angel
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 61
- Lead/follow: no public data
Portfolio highlights
- Vytal.ai — Vytal allows for brain health evaluation in minutes with just a laptop. Take control of your cognitive health.
- Akhetonics — Creating the first all-optical RISC Processor
- Greena World — In a world where travel connects us, we often overlook the impact we leave behind. Tourism accounts for over 8% of global CO2 emissions. Beyond environmental challenges like deforestation, pollution, and water scarcity, local communities also face pressure, experiencing changes in their traditions and ways of life.With expertise from SwanseaUniversity and the United Nations, our team recognised these challenges and envisioned a world where travel helps, not harms. Introducing Greena World. More than just a piece of technology, it's a guide for hotels and restaurants, helping them understand, improve, and share their impact on both the environment and local communities.The true beauty of embracing sustainability? The rewards. With the Greena Index, businesses can improve their sustainability and, in doing so, unlock a new market of over 100+ million eco-conscious travellers, boost revenues, and save on operating costs.The sustainable tourism sector is rapidly expanding, currently valued at $75B and witnessing a growth rate of 9.7% each year. While our initial focus is on hotels and restaurants, the Greena Index has ambitions to reshape the entire spectrum of the industry, from airlines to activities and destinations.Join us on a mission to transform the entire tourism industry for many generations to come.
A Diversified Company focused on multiple area of the cannabis hemp and CBD industry.
Show more...Investment focus
- Industry: AgTech, Medical, Cannabis
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Almoayed Ventures is the venture arm of Almoayed General W.L.L. The company focuses on partnering with investment professionals with a track record of supporting and scaling innovative businesses. The company also makes direct investments in passionate entrepreneurs and supports them throughout their journey.
Show more...Investment focus
- Industry: Health Care, Information Technology, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, India, United Arab Emirates
Investor stats
- Total investments: 15
- Round size: Seed $1.2M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BizzTM — BizzTM is a company that provides a variety of e-commerce categories of products through an aggregated delivery model.
- Ridepanda — Employer sponsored leases on the widest selection of pedal bikes, e-bikes and e-scooters from top brands.
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Global impact fund focusing on biotech, medtech and agritech investments that make a difference
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
investing in the future.
Show more...Investment focus
- Industry: Health Care, Life Science
- Stage:Pre-Seed
- Geography: United Arab Emirates
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Takalam — Takalam is an online counseling platform for a digital solution for mental well-being.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 118
- Round size: Series A $4.5M–$30M; Series B $12M–$115M; Series C $5.6M–$65M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Mariana Oncology — Mariana Oncology is a biotechnology research industry.
- Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Israel, The Netherlands
Investor stats
- Total investments: 78
- Round size: Seed $605k–$4.1M; Series A $1.3M–$20M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
- Anavo Therapeutics — UNLOCKING THE PHOSPHATASE TARGET CLASS: Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
- Celestial AI — We develop audacious AI computing platforms that elevate performance, energy and economic efficiencies, enabling our customers to rapidly deploy innovations in their AI applications.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Hardware
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Seed $1M–$1M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
- Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Round size: Seed $5M–$8M; Series B $16M–$50M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Belgium
Investor stats
- Total investments: 82
- Round size: Seed $1.3M–$14M; Series A $3.8M–$29M; Series B $11M–$50M
- Lead/follow: 49% lead, 51% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Talisman Capital Partners operates as a private investment company.
Show more...Investment focus
- Industry: Information Services, Pet, News
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Hong Kong
Investor stats
- Total investments: 6
- Round size: Series A $15M–$17M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
- Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
- qServe Communications — At qServe Communications, it is their unique vision to be a one-stop source for all your maintenance and development needs. They understand the difficulty of locating reliable companies to meet all of your infrastructure requirements. qServe has built an answer to this problem, a national service network of in-house employees to deliver qualitymanagement, installation, erection, inspection and maintenance services to the communications industry.With their full spectrum of project and program management services, they drive your project from start to finish, becoming an integral part of your development team. Many of qServe Communications crews and staff bring many years of valuable experience in the development of communications systems and infrastructures. From Program and Project Management to in-house installation and maintenance services, qServe will work diligently to ensure your project's success.qServe has performed thousands of projects for clients including: AT&T Wireless Services, Alltel Mobile, Nextel, Sprint, Omnipoint, Bell Atlantic Mobile, Teligent, Metricom, American Tower, Crown Castle and SBA Communications Corporation.
TPY Capital is a Tel Aviv based early state VC, investing in some of Israel’s most talented entrepreneurs. They are active investors who typically lead rounds in the areas we invest in, which include data and analytics, digitization and human augmentation, fintech, and frontier tech such as quantum computing.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Big Data
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, France
Investor stats
- Total investments: 32
- Round size: Seed $3.5M–$6.5M; Series A $3M–$21M; Series B $10M–$17M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Konnecto — Market Intelligence | Konnecto | Prescriptive Analytics Konnecto is a GTM Intelligence Platform that provides brands with an ongoing blueprint on how to increase online sales and improve marketing ROI
- ReturnGO — Easy-to-use self-service return management portal that allows customers to return and exchange products increases revenue and customer retention.
- Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.
Show more...Investment focus
- Industry: E-Commerce, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed
- Geography: Palestinian Territory, United States, Jordan
Investor stats
- Total investments: 26
- Round size: Seed $150k–$600k; Pre-Seed $60k–$250k
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Vatrin — Vatrin provides an easy way for small-business owners to set up a simple website to facilitate online orders, payments and a direct connection to WhatsApp for managing and tracking the final order.
- DataQueue — Unlock the true power of artificial intelligence with DataQueue. Our platform offers a transformative approach to AI lifecycle management, providing end-to-end solutions that cover every step of the process. From data labeling and automation to deployment and human-in-the-loop integration, we have
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 45
- Round size: Seed $3.3M–$9M; Series A $5.5M–$23M; Series B $25M–$74M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
- DeepChecks — Continuous validation for machine learning. Validate and monitor your data and models during training, production and new version releases.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Middle East Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!